Stay updated on Niraparib + Dostarlimab in Platinum Resistant Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Niraparib + Dostarlimab in Platinum Resistant Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Niraparib + Dostarlimab in Platinum Resistant Ovarian Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The revision label updated from v3.5.3 to v3.5.4, indicating a new version of the page template or content deployment. This reflects a deployment of an updated page version rather than a change to visible content.
    Difference
    0.0%
    Check dated 2026-05-15T14:25:28.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page’s displayed software/webpage revision version was updated from v3.5.2 to v3.5.3 without changing any underlying study details.
    Difference
    0.0%
    Check dated 2026-04-24T05:54:24.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:21:10.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added and Revision: v3.4.3 was removed.
    Difference
    0.0%
    Check dated 2026-03-18T21:07:56.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-11T20:10:13.000Z thumbnail image
  8. Check
    94 days ago
    Change Detected
    Summary
    A minor site revision tag (Revision: v3.4.2) was added, and the previous government funding notice about updates and operations was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T02:39:51.000Z thumbnail image

Stay in the know with updates to Niraparib + Dostarlimab in Platinum Resistant Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Niraparib + Dostarlimab in Platinum Resistant Ovarian Cancer Clinical Trial page.